elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q35210630-2AD34DE6-403A-4EC4-A60E-198F5C50014C
Q35210630-2AD34DE6-403A-4EC4-A60E-198F5C50014C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35210630-2AD34DE6-403A-4EC4-A60E-198F5C50014C
Patient cost sharing and receipt of erythropoiesis-stimulating agents through medicare part D.
P2860
Q35210630-2AD34DE6-403A-4EC4-A60E-198F5C50014C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35210630-2AD34DE6-403A-4EC4-A60E-198F5C50014C
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
46e7a43e105fdb31828ac410af4a322727f41493
P2860
Patterns of erythropoiesis-stimulating agent use among Medicare beneficiaries with myelodysplastic syndromes and consistency with clinical guidelines.